Further, we use genome-wide CRISPR/Cas9 gene-editing technology to knock out every gene in an MYC-driven cancer cell line cultured as a monolayer under normoxia and 1% oxygen, or in 3D spheroids under normoxia, followed by comprehensive comparative analyses of cellular fitness genes under these three conditions. The gene discussed is MYC; the disease is cancer.